Quantum-Si (QSI)
NASDAQ:QSI
QSI Stock Chart & Stats
$0.79
-$0.96(-27.61%)
At close: 4:00 PM EST
$0.79
-$0.96(-27.61%)
Day’s Range― - ―
52-Week Range$0.69 - $3.10
Previous CloseN/A
Volume35.47M
Average Volume (3M)3.21M
Market Cap
$160.22M
Enterprise Value$137.45M
Total Cash (Recent Filing)$162.91M
Total Debt (Recent Filing)$4.17M
Price to Earnings (P/E)―
Beta2.65
Next Earnings
May 07, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding196,431,270
10 Day Avg. Volume2,463,210
30 Day Avg. Volume3,213,966
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.99
Price to Sales (P/S)89.30
P/FCF Ratio-2.24
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue56.43
Enterprise Value/Gross Profit-41.64
Enterprise Value/Ebitda-1.32
Forecast
1Y Price Target
$2.50Price Target Upside216.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.43
Revenue Forecast (FY)$1.07M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthAnalyst highlights a strong balance sheet that provides financial flexibility to fund Proteus development and support a commercial launch.
Commercialization StrategyAnalyst notes management is prioritizing commercialization of the Proteus platform over legacy Platinum sales, which could shift revenue mix toward higher-growth products as market adoption grows.
High-value Product ApplicationsAnalyst believes Proteus capabilities could enable high-value use cases such as detailed protein modification analysis and sequencing of antibody variable regions, positioning the platform for premium market opportunities.
Bears Say
Financial Performance WeaknessCompany results came in below expectations with weaker revenue and declining gross margin, underscoring near-term profitability challenges.
Go-to-market And Near-term Revenue VisibilityCompany's shift to prioritize Proteus adoption over instrument placements implies near-term revenue may be modest and more dependent on consumables than new system sales.
Revenue Recognition RiskAnalyst notes embedded upgrade credits will defer revenue recognition until upgrades occur, creating a potential backlog of unrecognized sales and earnings pressure.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.69 and its highest was $3.10 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $160.22M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is May 07, 2026 which is in 23 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Mar 03, 2026. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.122 by $0.042.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.11.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 196,431,270 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.122. Following the earnings report the stock price went down -4.008%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (216.46% Upside)
$2.50 (216.46% Upside)
Blogger Sentiment
Bearish
QSI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 588.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $504.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.75%
12-Months-Change
Fundamentals
Return on Equity
-43.90%
Trailing 12-Months
Asset Growth
-0.57%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
QSI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but deliberate narrative: strong technical progress on Proteus, meaningful product and scientific milestones, a successful placement program and a healthy cash position that supports execution. These positives are tempered by very low near-term revenue, Q4 margin compression, significant GAAP charges and the need to demonstrate commercial traction and reliable manufacturing for Proteus. Management frames 2026 as a planned transition year prioritizing long-term platform value over near-term revenue.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.50
▲(216.46% Upside)
Technical Analysis
Ownership Overview
21.75% Insiders
7.07% Mutual Funds
9.76% Other Institutional Investors
49.49% Public Companies and Individual Investors